News for Inogen, Inc. (INGN)

Overview of BlackRock's Recent Transaction On June 30, 2025, BlackRock, Inc. (Trades, Portfolio), a leading investment firm, executed a transaction involving In

[url="]Inogen, Inc.[/url] (Nasdaq: [url="]INGN[/url]), a medical technology company offering innovative respiratory products for use in the homecare setting, t

Inogen, Inc. (INGN) to disclose Q2 2025 financial results on August 7, 2025. A conference call to discuss the results will be held at 2:00 p.m. PT / 5:0

[url="]Inogen, Inc.[/url] (Nasdaq: [url="]INGN[/url]), a leading medical technology company specializing in innovative respiratory products for homecare use, t

On June 16, 2025, B. Riley Securities initiated coverage on Inogen (INGN) with a

Inogen stabilizes sales and reduces losses, but modest growth and margin pressure persist despite new products and a China deal. Click for my INGN stock update.

Analyst Anderson Schock from B. Riley has begun coverage on Inogen (INGN) with a Buy recommendation and a price target set at $14. Inogen, recognized for its le

B. Riley has begun its coverage of Inogen (INGN) with a positive outlook, assigning a Buy rating and a price target of $14. This new coverage suggests confidenc

Inogen (INGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Needham's Mike Matson upgrades Inogen to Buy, citing turnaround progress, margin gains, and path to EBITDA breakeven by 2025.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

On May 22, 2025, Inogen (INGN) received a significant upgrade from the analyst firm Needham. The analyst, Mike Matson, has elevated the company's rating from a

In a recent update, Needham has elevated its rating for Inogen (INGN) from Hold to Buy, setting a price target of $12. The firm cites substantial advancements b

Inogen, Inc. (NASDAQ:INGN) Q1 2025 Earnings Conference Call May 7, 2025 5:00 PM ETCompany ParticipantsRyan Peterson - Investor RelationsKevin Smith -...

Although the revenue and EPS for Inogen (INGN) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

\n[url=\

\n Inogen Inc. (INGN) will announce its Q1 2025 financial results on May 7, 2025, post-market close. A conference call discussing the results is scheduled

BOSTON, April 15, 2025 /PRNewswire/ -- Below is the March 2025 Monthly Update for the Liberty All-Star Growth Fund, Inc. (NYSE:ASG).

Inogen (INGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.